RE:Nice 14+% jump today!MCI has been growing its primary care clinics for a few years now and prior to the onset of the Covid-19 crisis, the company was generating revenue nearing $50m.
As the general population becomes fully vaccinated and life returns to some sense of normalcy, I expect we might see an increase in revenue growth which in turn should give us an enhanced share price.
As far as I can ascertain, Doug Taylor of Canaccord Genuity is/was the only analyst covering MCI... he was focasting a target price of $5.50 ps.
Hopefully, we will see an update very soon and even additional analyst coverage.